Page last updated: 2024-11-04

sarpogrelate and Ventricular Dysfunction, Left

sarpogrelate has been researched along with Ventricular Dysfunction, Left in 1 studies

sarpogrelate: structure given in first source

Ventricular Dysfunction, Left: A condition in which the LEFT VENTRICLE of the heart was functionally impaired. This condition usually leads to HEART FAILURE; MYOCARDIAL INFARCTION; and other cardiovascular complications. Diagnosis is made by measuring the diminished ejection fraction and a depressed level of motility of the left ventricular wall.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sanganalmath, SK1
Barta, J1
Takeda, N1
Kumamoto, H1
Dhalla, NS1

Other Studies

1 other study available for sarpogrelate and Ventricular Dysfunction, Left

ArticleYear
Antiplatelet therapy mitigates cardiac remodeling and dysfunction in congestive heart failure due to myocardial infarction.
    Canadian journal of physiology and pharmacology, 2008, Volume: 86, Issue:4

    Topics: Animals; Arrhythmias, Cardiac; Cilostazol; Disease Models, Animal; Echocardiography; Electrocardiogr

2008